GLP-1 receptor agonists-a potential therapy for chronic kidney disease?

More on GLP-1 receptor agonists

• GLP-1 agonists plus SGLT2 inhibitors lower kidney events in CKD

  Diabetes, Obesity & Metabolism · 4 Oct 2026

• SGLT2 inhibitors match GLP-1 drugs for overall kidney outcomes

  Clinical Journal of the American Society of Nephrology · 4 Oct 2026

• GLP-1 receptor agonists link to lower stroke and Alzheimer risk

  Neurology Genetics · 4 Oct 2026

• Semaglutide curbs kidney vascular resistance and fibrosis

  Nature Medicine · 4 Oct 2026